Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | PSMA vs AXUMIN PET/CT in prostate cancer

Jeremie Calais, MD, from the University of California, Los Angeles, CA, talks about 18F-fluciclovine (AXUMIN) vs 68Ga-PSMA-11 (PSMA) PET/CT molecular imaging in prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.